News

Jed Dorsheimer, William Blair analyst, joins 'The Exchange' to discuss Tesla's chip deal with Samsung and what it means for ...
Vertiv Holdings (NYSE:VRT) on Monday was rated Outperform in new research coverage by analysts at investment firm William ...
William Blair cheers Tesla-Samsung chip deal but keeps TSLA at Hold, citing auto margin woes and valuation concerns.
In addition, The Allstate Corporation (NYSE:ALL) is taking advantage of a far better auto loss environment and employing ...
Costco Wholesale Corporation (NASDAQ:COST) ranks among the best low volatility stocks to buy according to analysts. William ...
In its own communique issued shortly after the FDA’s, Sarepta elaborated on the situation and confirmed a Roche statement to ...
William Blair analysts lowered their rating on Ameriprise stock to Market Perform from Outperform Friday following the financial services firm’s second-quarter report.
The U.S. Food and Drug Administration (FDA) announced on Friday, after market close, that it is investigating the death of an ...
Discover Kforce's Q2 2025 results: sequential revenue growth, AI-driven strategies, and consulting-led solutions amid market uncertainty.
Sarepta Therapeutics’ stock has dropped precipitously as questions swirl around the safety of its gene therapies. Meanwhile, ...
Brazilian authorities said the death was unlikely to have been caused by Elevidys and was instead more in line with severe ...
Palantir Technologies Inc. (NASDAQ:PLTR) ranks among the best momentum stocks to buy. Palantir Technologies Inc. (NASDAQ:PLTR) was awarded a $100 million contract by the U.S. Army to the ...